ArticleFrontiers in neurology2025
Advancing neuro-ophthalmic diagnostics: a multimodal imaging approach integrating OCT angiography and AI-enhanced MRI for improved visual pathway analysis.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recent advancements in neuro-ophthalmology necessitate integrative imaging methodologies to address the structural and functional complexities of the visual pathway. Conventional diagnostic tools, including magnetic resonance imaging (MRI) and optical coherence tomography (OCT), are constrained by limitations in spatial resolution, cross-modality integration, and interpretability, often resulting in diagnostic uncertainty in cases involving compressive neuropathies, demyelinating diseases, or unexplained visual field deficits. Deep learning approaches, despite their computational power, lack anatomical specificity and fail to incorporate domain knowledge critical for clinical interpretability. Methods: To address these challenges, we propose a multimodal framework that integrates OCT angiography with AI-enhanced MRI analysis through a symbolic-neural architecture. This framework employs the NeuroGraphPath model, which represents the visual pathway as a directed graph with anatomically defined nodes and parameterized transformations between regions, including the retina, optic chiasm, lateral geniculate nucleus (LGN), and visual cortex. The model incorporates spatial embeddings, learned decussation mechanisms, and anomaly detection modules to ensure biologically grounded and interpretable diagnostics. Additionally, the Chiasmatic Flow Inversion strategy facilitates bidirectional reasoning, enabling the tracing of activations to probable lesion sites with quantified uncertainty. Results and Discussion: Empirical evaluations demonstrate superior performance in lesion localization, uncertainty-aware reasoning, and interpretability compared to baseline AI models, particularly in complex visual field presentations. This integrated approach advances neuro-ophthalmic diagnostics by bridging imaging modalities and embedding anatomical reasoning, addressing the growing demand for precision and explainability in medical imaging research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.